Biomarker Market Research Reports

Biomarker Market

The biomarkers market research reports analyze the global biomarkers industry. These research reports review and e... view more

RSS Sort By :
TITLE Price Buy Now More options

The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies.Trends in bioma...

$ 2995


TechNavio's analysts forecast the Global Imaging Biomarkers market to grow at a CAGR of 15.09 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Imagi...

$ 2000


The effectiveness of biomarkers has made them essential to medicine, with successful products on the market and many products in development. This Kalorama Information report focuses on both the clinical biomarkers and research biomarkers in medic...

$ 3995


Cancer/Tumor profiling is a promising market and is witnessing significant growth in the healthcare industry. It is poised to grow rapidly in a range of application areas, including biomarker discovery and prognosis. The global cancer/tumor profil...

$ 4650


A biomarker is an identifiable and measurable characteristic, which identifies the severity and/or occurrence of a specific disease. It has major applications in the discovery and development of novel therapeutic drugs. The global biomarkers marke...

$ 4650


This market report from SELECTBIO represents the most up-to-date analysis of the Epigenetic and MicroRNA Biomarkers spaces together with research market data [qualitative and quantitative analysis] characterizing the epigenetics and microRNA resea...

$ 2000


Aptamers is an emerging market, widely considered as a rival or substitute to antibodies in the scientific industry. It is poised to grow rapidly in various application areas, including therapeutics and diagnostics. The global aptamers market is v...

$ 4650


Alzheimer’s disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, cognitive impairment, and functional decline. The disease has emerged as a major global health priority especially because of its rapid...

$ 3995


MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - Global Analysis and Market Forecasts Summary Acute coronary syndrome (ACS) consists of two major diseases: myocardial infarction (MI) and unstable angina, with the former b

$ 6495


MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - Current and Future Players Summary Acute coronary syndrome (ACS) consists of two major diseases: myocardial infarction (MI) and unstable angina, with the former being one o

$ 3500


MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - EU Analysis and Market Forecasts Summary In Europe, the ACS in vitro diagnostics market is dominated by a single biomarker test, cardiac troponins. However, this market rem

$ 4450


MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - US Analysis and Market Forecasts Summary In the US, the ACS in vitro diagnostics market is dominated by a single biomarker test, cardiac troponins. However, this market rem

$ 4450


MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts Summary The ACS in vitro diagnostics market is dominated by a single biomarker test, cardiac troponins. However, this market remains of h

$ 4450


MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - South America Analysis and Market Forecasts Summary This report focuses on the Diagnostic Cardiac Biomarkers market in South America, principally Brazil. The ACS in vitro d

$ 4450


Over the last decade, genomics and proteomics have been used as key tools to discover potential drug targets and to better understand the complexities of biology. To balance research in these areas, metabolomics, a new science is evolving for anal...

$ 4650


TechNavio''s analysts forecast the Global Cancer Biomarkers market to grow at a CAGR of 18.22 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prev...

$ 2000


GBI Research’s new report, Biomarkers in Drug Discovery Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes” provides information and analysis on the major trends and issues affectin...

$ 3500


GBI Research in its report Endpoints Clinical Trials in Respiratory Diseases Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles” presents the use of endpoints or outcomes measures in respi...

$ 3500


GBI Research in its report Endpoints- Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles” presents the use of endpoints or outcomes measures in re...

$ 3500


Over 1,200 pages of cutting-edge research detailing the most important markets in today's diagnostic industry!Three in One Report Bundle! (Plus a bonus survey.) Combined these reports would be over $8,490 (single user license). As a bun...

$ 5995

Live Chat Support
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

> Live Chat
Live Chat by Comm100